Master Regulatory Gene Network (MRGN) (MRGN)

The Master Regulatory Gene Network (MRGN) is a core regulatory state identified in glioblastoma (GBM), particularly within glioblastoma stem-like cells (GSCs). This network is restructured by founding mutations and maintained across various subclones, contributing to the profound heterogeneity and therapeutic resistance characteristic of GBM (Source 3.2.1, 5.3.1). The MRGN is anchored by developmentally restricted master regulators (MRs) that are essential for maintaining the GSC state and driving tumor growth (Source 3.2.2, 5.3.2). Therapeutic strategies targeting the MRGN utilize AI-directed identification (such as the NETZEN suite) to pinpoint key master regulators, which are then targeted using shRNA-based gene therapies delivered via viral vectors like adeno-associated virus (AAV) (Source 4.2.4, 5.2.2). By disrupting this core regulatory network, these therapies aim to force GSCs into a differentiated or apoptotic state, providing a heterogeneity-agnostic approach to treating glioblastoma (Source 3.2.1, 5.3.1).

Other names

GBM Master Regulatory Gene NetworkGSC Master Regulatory Gene NetworkGlioblastoma Master Regulatory Gene Network

shRNA-mediated knockdown of master regulators within the network to disrupt the oncogenic state and induce differentiation or cell death.